"Pharmacovigilance" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The detection of long and short term side effects of conventional and traditional medicines through research, data mining, monitoring, and evaluation of healthcare information obtained from healthcare providers and patients.
| Descriptor ID |
D060735
|
| MeSH Number(s) |
E05.337.800.600 N06.850.505.636
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Pharmacovigilance".
Below are MeSH descriptors whose meaning is more specific than "Pharmacovigilance".
This graph shows the total number of publications written about "Pharmacovigilance" by people in this website by year, and whether "Pharmacovigilance" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 0 | 1 | 1 |
| 2017 | 9 | 8 | 17 |
| 2018 | 15 | 12 | 27 |
| 2019 | 6 | 6 | 12 |
| 2020 | 3 | 4 | 7 |
| 2021 | 3 | 9 | 12 |
To return to the timeline, click here.
Below are the most recent publications written about "Pharmacovigilance" by people in Profiles.
-
Key Contributions in Clinical Research Informatics. Yearb Med Inform. 2021 Aug; 30(1):233-238.
-
Association of Facial Paralysis With mRNA COVID-19 Vaccines: A Disproportionality Analysis Using the World Health Organization Pharmacovigilance Database. JAMA Intern Med. 2021 09 01; 181(9):1243-1245.
-
Numbers of spontaneous reports: How to use and interpret? Br J Clin Pharmacol. 2022 03; 88(3):1365-1368.
-
Adverse drug event risk assessment by the virtual addition of COVID-19 repurposed drugs to Medicare and commercially insured patients' drug regimens: A drug safety simulation study. Clin Transl Sci. 2021 09; 14(5):1799-1809.
-
From program suspension to the pandemic: A qualitative examination of Australia's vaccine pharmacovigilance system over 10 years. Vaccine. 2021 09 24; 39(40):5968-5981.
-
Informed consent and informed intervention: SARS-CoV-2 vaccinations not just call for disclosure of newly emerging safety data but also for hypothesis generation and testing. Eur J Med Res. 2021 Aug 06; 26(1):87.
-
Liver injury following SARS-CoV-2 vaccination: A multicenter case series. J Hepatol. 2022 01; 76(1):211-214.
-
Auto-immune hepatitis following COVID vaccination. J Autoimmun. 2021 09; 123:102688.
-
Thrombotic complications of vaccination against SARS-CoV-2: what pharmacovigilance reports tell us - and what they don't. Eur Respir J. 2021 07; 58(1).
-
AI-based language models powering drug discovery and development. Drug Discov Today. 2021 11; 26(11):2593-2607.